You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INLYTA®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023

Melanoma Trial in Tampa (Ipilimumab, Axitinib)

Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Carcinoma, Renal Cell, Fumarate Hydratase Deficiency, Immunotherapy Trial in Chengdu (Sintilimab injection plus Inlyta

Recruiting
  • Carcinoma, Renal Cell
  • +2 more
  • Sintilimab injection plus Inlyta treatment
  • Chengdu, Sichuan, China
    West China Hospital
Jul 11, 2021

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
Has Results
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)

Active, not recruiting
Has Results
  • Alveolar Soft Part Sarcoma
  • Soft Tissue Sarcomas
  • Miami, Florida
    University of Miami
Dec 29, 2022

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Observe Safety and Efficacy of Inlyta in South Korea

Recruiting
  • Advanced Renal Cell Carcinoma
    • Seoul, Korea, Republic of
      Pfizer Tower
    Feb 5, 2021

    Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

    Available
    • Clear Cell Kidney Cancer
    • +2 more
    • Axitinib 5 MG
    • (no location specified)
    Jul 3, 2023

    Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +2 more
    Jun 27, 2022

    Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)

    Completed
    • Recurrent ACC, metastaticACC, Unreaectable ACC
    • Seoul, Korea, Republic of
      Department of Internal Medicine, Seoul National University Hospi
    Mar 26, 2022

    Patterns With Targeted Therapies In Mrcc In Sweden - A

    Completed
    • Kidney Neoplasms
    • Sollentuna, Sweden
      Pfizer Innovations AB
    Sep 8, 2021

    Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

    Active, not recruiting
    Has Results
    • Renal Cell Carcinoma
    • Pembrolizumab
    • +2 more
    • (no location specified)
    Aug 17, 2022

    Cervical Cancer Trial in Hong Kong (Avelumab, Axitinib)

    Recruiting
    • Cervical Cancer
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Feb 23, 2022

    Axitinib Therapy Management Study

    Withdrawn
    • Renal Cell Carcinoma
    • New York, New York
      Pfizer Inc.
    Mar 25, 2022

    Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

    Recruiting
    • Cancer
    • +3 more
    • Aalborg, Denmark
    • +6 more
    Oct 25, 2022

    Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

    Completed
    Has Results
    • Neurofibromatosis Type 2
    • Vestibular Schwannomas
    • New York, New York
      NYU Langone Medical Center
    Nov 24, 2021

    Endometriosis, Endometriosis Ovary, Endometriosis Externa Trial in Basel (Linifanib, BIBW2992, Axitinib)

    Withdrawn
    • Endometriosis
    • +3 more
    • Linifanib
    • +2 more
    • Basel, Вâlе, Switzerland
      BioGene Pharmaceutical Ltd.
    Oct 24, 2021

    Solitary Fibrous Tumor Trial in Milan (Axitinib)

    Completed
    • Solitary Fibrous Tumor
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Naazionale dei Tumori
    Sep 22, 2021

    NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

    Active, not recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Non-small Cell Lung Cancer Stage III
    • La Jolla, California
    • +5 more
    Aug 12, 2022

    Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

    Recruiting
    • Papillary Renal Cell Carcinoma Type 2
    • Axitinib Oral Tablet [Inlyta]
    • Pembrolizumab Injection [Keytruda]
    • Angers, France
    • +11 more
    Aug 26, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 16, 2021

    Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

    Not yet recruiting
    • Melanoma Stage IV
    • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
    • +2 more
    • (no location specified)
    Sep 27, 2021

    Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

    Active, not recruiting
    • Metastatic Malignant Neoplasm in Lymph Node
    • +3 more
    • Antiandrogen Therapy
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 3, 2022

    Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Pembrolizumab, Axitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Clear Cell Renal Cell Carcinoma
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Jul 30, 2021